| 1 |
杨毅, 邱海波. 打赢新型冠状病毒感染肺炎疫情阻击战: 重症医学必须走在前面 [J/OL]. 中华重症医学电子杂志, 2020, 6 (00): E002-E002.
|
| 2 |
Zador Z, Landry A, Balas M, et al. Data driven analysis reveals shared transcriptome response, immune cell composition, and distinct mortality rates across differing etiologies of critical illness [J]. Crit Care Med, 2020, 48(3): 338-343.
|
| 3 |
Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J]. Lancet, 2020, 395(10224): 565-574.
|
| 4 |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [J]. Lancet Respir Med, 2020, 8(4): 420-422.
|
| 5 |
Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China [J]. Cell Host Microbe, 2020, 27(3): 325-328.
|
| 6 |
Skariyachan S, Challapilli SB, Packirisamy S, et al. Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East respiratory syndrome coronavirus infections [J]. Front Microbiol, 2019, 10: 569.
|
| 7 |
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus [J]. Nature, 2003, 426(6965): 450-454.
|
| 8 |
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [J]. JAMA, 2020, 323(11): 1061-1069.
|
| 9 |
Clohisey S, Baillie JK. Host susceptibility to severe influenza A virus infection [J]. Crit Care, 2019, 23(1): 303.
|
| 10 |
Streicher F, Jouvenet N. Stimulation of innate immunity by host and viral RNAs [J]. Trends Immunol, 2019, 40(12): 1134-1148.
|
| 11 |
Hill AA, Diehl GE. Identifying the patterns of pattern recognition receptors [J]. Immunity, 2018, 49(3): 389-391.
|
| 12 |
Du L, Zhao G, Chan CC, et al. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity [J]. Virology, 2009, 393(1): 1441-1450.
|
| 13 |
Xu J, Jia W, Wang P, et al. Antibodies and vaccines against Middle East respiratory syndrome coronavirus [J]. Emerg Microbes Infect, 2019, 8(1): 841-856.
|
| 14 |
刘军. 正确理解危重病免疫功能障碍免疫与炎症的关系 [J]. 中华医学杂志, 2017, 97(7): 483-486.
|
| 15 |
Chen S, Liu G, Chen J, et al. Ponatinib protects mice from lethal influenza infection by suppressing cytokine storm [J]. Front Immunol, 2019, 10: 1393.
|
| 16 |
奚晶晶, 马朋林. 新型冠状病毒肺炎重症患者的管理 [J/OL]. 中华重症医学电子杂志, 2020, 6 (00): E006-E006.
|
| 17 |
Imai Y, Kuba K, Rao S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure [J]. Nature, 2005, 436(7047): 112-116.
|
| 18 |
Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury [J]. Nat Med, 2005, 11(8): 875-879.
|
| 19 |
刘军, 邱海波. 血管紧张素Ⅱ在急性肺损伤中作用的研究进展 [J]. 中华内科杂志, 2010, 49(11): 981-983.
|
| 20 |
Liu J, Zhang PS, Yu Q, et al. Losartan inhibits conventional dendritic cell maturation and Th1 and Th17 polarization responses: Novel mechanisms of preventive effects on lipopolysaccharide-induced acute lung injury [J]. Int J Mol Med, 2012, 29(2): 269-276.
|